Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
30 participants
INTERVENTIONAL
2019-09-04
2022-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Network analysis of functional connectivity (FC) patterns estimated from neuroimaging techniques such as electroencephalography (EEG), magnetoencephalography (MEG) and functional magnetic resonance imaging (fMRI) has allowed a major breakthrough in the understanding of physiopathology of stroke from a system perspective. Recent evidence from cross=sectional studies1,2 highlights that stroke lesions generally induce i) critical deviation from optimal (i.e. small=world) network topologies supporting both segregated and integrated information processing, ii) altered inter=hemispheric connectivity and modularity, iii) and abnormal region centrality in the ipsilesional hemisphere as well as in the contralesional hemisphere. While these findings provide new descriptors on how stroke lesions affect the functional brain network organization and how this correlates with the resulting behavioral impairment (e.g. hemiplegia, aphasia), they only represent a static picture of the brain plasticity, which is instead intrinsically dynamic, and partially inform on the chances of single patients to recover their motor/cognitive functions. These aspects dramatically limit the investigator's ability to fully understand the brain organizational mechanisms after stroke and to probe the predictive power of possible network=based neuromarkers of recovery. The ATTACK project aims to overcome these technological and methodological barriers by implementing the following three=fold strategy:
1. acquiring a longitudinal dataset of brain and behavioral data in stroke patients and healthy controls,
2. developing new analytic tools to characterize and generate temporally dynamic brain networks,
3. building network=based models of functional recovery after stroke, accounting for individual patients.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Motor Changes Associated With Recovery From Stroke After Therapy
NCT00001553
Neurofeedback for Upper-limb Recovery After Stroke
NCT03766113
Impact of rTMS on BCI Control in Upper Limb Motor Rehabilitation of Patients With Chronic Stroke
NCT06951035
Establishing a Prognostic Model for Stroke Recovery
NCT05332652
Combination of Motor Imagery Exercises and Brain Stimulation TMS Type PAS in Patients After Hemiplegic Stroke
NCT02779218
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
ATTACK focuses on the acquisition of a longitudinal dataset (15 patients and 15 age=matched healthy controls). Multimodal data (clinical/functional scales, behavioral measures, brain activity EEG) will be collected from each patient at different phases after stroke across a series of consecutive recording sessions, i.e. +10 days, +1 month, +3 months, +6 months, +12 months after the first stroke event
Patients will be selected with the following inclusion criteria: first=ever infarct lesion, with hand motor impairment. Exclusion criteria will be aged 18 to 85 years, inability to understand the task or perform motor tasks, contraindication to MRI. In each session, patients will be asked to perform several trials of resting state and hand grasping tasks (imagery and execution) in order to study also the intra=session brain changes occurring at short=time scales. Differently from current approaches focusing on fMRI changes, the present project focuses on high= density (64 sensors) EEG data in order to exploit the higher temporal resolution (in the order of ms) and have a much clearer understanding of the motor processes occurring at rapid oscillatory ranges (e.g. ERD/ERS). Furthermore, the high portability of EEG systems has the advantage to perform recording sessions at the patient's bedside, or even at home, in a totally non=invasive way, thus decreasing the impact on patient life in the hospital.
Clinical and behavioral data will be also collected from each patient to assess their motor recovery progress. Different scores include the ARAT, hand grip strength, NIHSS with motor subitems and Rankin score. Finally, anatomical MRI (T1 and tensor imaging) scan will be acquired for each patient after the subacute phase (+3 months) in order to locate and assess the severity/size of the lesion. These scores and data will be eventually used as covariates for the brain network topological changes. The first recording session will be performed at the Stroke unit of the Hospital Pitié\_Salpêtrière. Subsequent sessions will be performed at the ICM, operated by the Centre EEG/MEG (CENIR).
The same data will be also collected at the ICM from the group of age-matched healthy subjects according to the same protocols and timing. This data are crucial in that they will be used to assess the statistical significance of the changes observed in the stroke patients. Recording sessions will be conducted in compliance with French regulations, including provisions relating to biomedical research in the Public Health Code, the French Bioethics law, the French Data Protection Act, and the World Medical Association Declaration of Helsinki.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Healthy volunteers
Subjects will be asked to perform:
* high= density (64 sensors) EEG
* clinical and behavioral data will be also collected from each subject to evaluate their motor skills: the ARAT or ACTION RESEARCH ARM TEST, hand grip strength, Fugl Meyer
* anatomical MRI (T1 and tensor imaging) scan)
Imaging
high= density (64 sensors) EEG and anatomical MRI (T1 and tensor imaging) scan
Clinical and behavioral testing : Motor skills
the ARAT or ACTION RESEARCH ARM TEST, hand grip strength, Fugl Meyer
Patients
Patients will be asked to perform:
* high= density (64 sensors) EEG
* clinical and behavioral data will be also collected from each patient to assess their motor recovery progress: the ARAT or ACTION RESEARCH ARM TEST, hand grip strength, NIHSS with motor subitems and Rankin and Barthel score, measure of functional independence and Hemispatial neglect, Fugl Meyer, test of Ashworth
* anatomical MRI (T1 and tensor imaging) scan)
Imaging
high= density (64 sensors) EEG and anatomical MRI (T1 and tensor imaging) scan
Clinical and behavioral testing : Motor recovery progress
NIHSS with motor subitems and Rankin and Barthel score, measure of functional independence and Hemispatial neglect, test of Ashworth
Clinical and behavioral testing : Motor skills
the ARAT or ACTION RESEARCH ARM TEST, hand grip strength, Fugl Meyer
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Imaging
high= density (64 sensors) EEG and anatomical MRI (T1 and tensor imaging) scan
Clinical and behavioral testing : Motor recovery progress
NIHSS with motor subitems and Rankin and Barthel score, measure of functional independence and Hemispatial neglect, test of Ashworth
Clinical and behavioral testing : Motor skills
the ARAT or ACTION RESEARCH ARM TEST, hand grip strength, Fugl Meyer
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Delay between stroke onset and inclusion=10 days
* Upper limb motor deficit assessed by the Fugl Meyer score
* Written consent given
* French health insurance
* MMSE score \> 26 for healthy volunteers
Exclusion Criteria
* Contra indication for MRI, unwilling to be informed a brain abnormality discovered on MRI other than the known one
* Life threatening condition during the year of follow up
* Surgery of the upper limb that impact the functional abilities
* Pregnancy, people under legal guardian
* Rankin score \> 2 before the stroke
* Subjects already involved in a therapeutic trial
* Territorial sequelae old to the imagery
18 Years
85 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Institut National de la Santé Et de la Recherche Médicale, France
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Urgences cérébro-vasculaires, Hôpital Pitié-Salpêtrière
Paris, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2018-A02765-50
Identifier Type: REGISTRY
Identifier Source: secondary_id
C17-75
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.